OAB and Incontinence

Nerve stim device provides long-term OAB symptom improvement

December 10, 2018

An investigational wireless, implantable tibial nerve stimulator is safe and provided improvement in overactive bladder symptoms over 3 years of follow-up.

Beta-3 agonist shows benefit for OAB in older adults

December 10, 2018

Mirabegron (Myrbetriq) is effective and well tolerated in patients age 65 or older with overactive bladder, results of a randomized, placebo-controlled study show.

OAB patients continue medical therapy unnecessarily

November 20, 2018

A recent study found that sacral neuromodulation monotherapy was efficacious as a third-line treatment.

Nearly 30% of U.S. women report nocturia

November 20, 2018

Nocturia appears to be highly prevalent in the United States, with almost 30% of all women reporting significant nocturia, according to new data reported at the AUA annual meeting in San Francisco.

Data shift thinking on nocturia’s causes, treatment

November 20, 2018

 Waking up at night to urinate is by far the most bothersome lower urinary tract symptom. 

Non-head MRI found safe in patients undergoing SNM

November 07, 2018

The therapeutic efficacy of sacral neuromodulation was not affected by non-head magnetic resonance imaging scans in a recent study.

More than 50% of patients stop botulinum treatment

November 07, 2018

Over half of patients stop intradetrusor botulinum toxin injections within 10 years, mostly due to lack of clinical efficacy, researchers say.

Large datasets shed light on benign urologic conditions

November 06, 2018

In this interview, J. Quentin Clemens, MD, discusses the work being done by the MAPP (Multidisciplinary Approach to Chronic Pelvic Pain) Research Network and LURN (Symptoms of Lower Urinary Tract Dysfunction Research Network) research initiatives.

Nocturia treatment efficacious after single dose

November 01, 2018

“The results suggest that this compound has rapid efficacy and a favorable safety profile in patients with nocturia due to nocturnal polyuria,” says researcher Diane Newman, DNP.

Botulinum toxin more cost-effective than SNM

November 01, 2018

Cost-effectiveness results favored botulinum toxin at 2 years as well as in an analysis at 5 years accounting for increased cost of the botulinum approach due to repeat injections, according to investigator Heidi S. Harvie, MD, MSCE.